Form D · Investing

Aspiriant Holdings S5, LLC

Los Angeles, CA · CIK 0001698385

Offering snapshot reported Apr 17, 2017 · SEC filing

Reported sold
$6.92M
Offering amount: $6.92M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 31, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 17, 2017Initial$6,916,638No comparison4SEC filing
Feb 21, 2017Initial$100No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-284959

Source: Form D, filed Apr 17, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Allen Executive
Kenneth J. Anderson Director
Karen Blodgett Director
Carl D. Forster Director
Lorraine Fox Director
Robert J. Francais Executive
Doug Hendrickson Executive
Neil Hokanson Director
Michael H. Kossman Director, Executive
Bret Magpiong Executive
Mark Petrie Director
Marc S. Primiani Executive
Thomas G. Tracy Executive

Issuer details

Industry: Investing (See others in industry)

Address:
11100 Santa Monica Bouleward, Suite 600
Los Angeles, CA, 90025